Extension Study Investigating Atogepant for the Treatment of Pediatric Subjects with Episodic Migraine.
Datos básicos
Documentos
- No hay documentos
Participantes
Grupos
Financiadores - Promotores
ABBVIE DEUTSCHLAND GMBH & CO. KG
Cita
Extension Study Investigating Atogepant for the Treatment of Pediatric Subjects with Episodic Migraine. (M21-199). ABBVIE DEUTSCHLAND GMBH & CO. KG. 2023IP:SAMUEL DIAZ INSA.
Portal de investigación